Vaccines are Big Money for Big Pharma
Vaccine sales are excpected to double, from $19 billion last year to $39 billion in 2013.
Omaha World Herald | Malaria. Tuberculosis. Alzheimer’s disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler’s diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.
Many vaccines could be on the market in five years or less.
Contrast that with five years ago, when so many companies had abandoned the vaccine business that half the U.S. supply of flu shots was lost because of contamination at one of the two remaining manufacturers.
No comments:
Post a Comment